{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T11:00:17Z","timestamp":1792839617794,"version":"4.5.0"},"reference-count":87,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","jcehepatology.com","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical and Experimental Hepatology"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.jceh.2024.101368","type":"journal-article","created":{"date-parts":[[2024,2,29]],"date-time":"2024-02-29T09:38:55Z","timestamp":1709199535000},"page":"101368","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Post-Liver Transplant Metabolic Syndrome"],"prefix":"10.1016","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6540-2623","authenticated-orcid":false,"given":"Ashok","family":"Choudhury","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1885-6996","authenticated-orcid":false,"given":"Satender P.","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9323-3051","authenticated-orcid":false,"given":"Akhil","family":"Desmukh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bishnupriya","family":"Sahoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Eslam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jceh.2024.101368_bib1","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1365-2036.2011.04724.x","article-title":"Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults","volume":"34","author":"Vernon","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jceh.2024.101368_bib2","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1002\/lt.21588","article-title":"Metabolic syndrome in liver transplantation: relation to etiology and immunosuppression","volume":"14","author":"Bianchi","year":"2008","journal-title":"Liver Transplant"},{"key":"10.1016\/j.jceh.2024.101368_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cld.2007.02.009","article-title":"Epidemiology and natural history of NAFLD and NASH","volume":"11","author":"Ong","year":"2007","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.jceh.2024.101368_bib4","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1002\/hep.25762","article-title":"The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American association for the study of liver diseases, American College of Gastroenterology, and the American gastroenterological association","volume":"55","author":"Chalasani","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2024.101368_bib5","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1097\/MEG.0000000000000820","article-title":"Nonalcoholic steatohepatitis recurrence and rate of fibrosis progression following liver transplantation","volume":"29","author":"Sourianarayanane","year":"2017","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2024.101368_bib6","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1053\/j.gastro.2019.11.312","article-title":"International consensus Panel. MAFLD: a consensus-driven proposed nomenclature for metabolic associated fatty liver disease","volume":"158","author":"Eslam","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jceh.2024.101368_bib7","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/lt.22198","article-title":"Metabolic syndrome in liver transplant recipients: prevalence, risk factors, and association with cardiovascular events","volume":"17","author":"Laish","year":"2011","journal-title":"Liver Transplant"},{"key":"10.1016\/j.jceh.2024.101368_bib8","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2024.101368_bib9","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.1210\/clinem\/dgac321","article-title":"Global prevalence and clinical characteristics of metabolic-associated fatty liver disease: a meta-analysis and systematic review of 10 739 607 individuals","volume":"107","author":"Chan","year":"2022","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.jceh.2024.101368_bib10","doi-asserted-by":"crossref","first-page":"e345","DOI":"10.1097\/TP.0000000000002916","article-title":"Incidence and risks for nonalcoholic fatty liver disease and steatohepatitis post-liver transplant: systematic review and meta-analysis","volume":"103","author":"Saeed","year":"2019","journal-title":"Transplantation"},{"key":"10.1016\/j.jceh.2024.101368_bib11","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/hep.29466","article-title":"Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease","volume":"67","author":"Estes","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2024.101368_bib12","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1111\/hpb.12435","article-title":"Metabolic syndrome after a liver transplantation in an Asian population","volume":"17","author":"Tan","year":"2015","journal-title":"HPB (Oxford)"},{"key":"10.1016\/j.jceh.2024.101368_bib13","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.cld.2012.05.011","article-title":"The genetic epidemiology of nonalcoholic fatty liver disease: toward a personalized medicine","volume":"16","author":"Sookoian","year":"2012","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.jceh.2024.101368_bib14","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1002\/lt.21126","article-title":"Metabolic syndrome in liver transplant recipients: prevalence and association with major vascular events","volume":"13","author":"Laryea","year":"2007","journal-title":"Liver Transplant"},{"key":"10.1016\/j.jceh.2024.101368_bib15","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1097\/00007890-200007270-00009","article-title":"Comparative allograft histology after liver transplantation for cryptogenic cirrhosis, alcohol, hepatitis C, and cholestatic liver diseases","volume":"70","author":"Maor-Kendler","year":"2000","journal-title":"Transplantation"},{"key":"10.1016\/j.jceh.2024.101368_bib16","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1002\/lt.25338","article-title":"Predictors of de novo nonalcoholic fatty liver disease after liver transplantation and associated fibrosis","volume":"25","author":"Galvin","year":"2019","journal-title":"Liver Transplant"},{"key":"10.1016\/j.jceh.2024.101368_bib17","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1053\/j.gastro.2015.04.043","article-title":"Liver fibrosis, but no other histologic features, associates with long-term outcomes of patients with NAFLD","volume":"149","author":"Angulo","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jceh.2024.101368_bib18","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1053\/j.gastro.2007.05.012","article-title":"Progressive fibrosis in NASH: association with altered regeneration and a ductular reaction","volume":"133","author":"Richardson","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jceh.2024.101368_bib19","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1002\/hep.26226","article-title":"Mitochondrial adaptations and dysfunctions in NAFLD","volume":"58","author":"Begriche","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2024.101368_bib20","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1042\/bj2310439","article-title":"Elevated hepatic mitochondrial and peroxisomal oxidative capacities in fed and starved adult obese (ob\/ob) mice","volume":"231","author":"Brady","year":"1985","journal-title":"Biochem J"},{"key":"10.1016\/j.jceh.2024.101368_bib21","doi-asserted-by":"crossref","first-page":"5692","DOI":"10.1074\/jbc.274.9.5692","article-title":"Obesity induces expression of uncoupling protein-2 in hepatocytes and promotes liver ATP depletion","volume":"274","author":"Chavin","year":"1999","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jceh.2024.101368_bib22","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/j.1365-2362.2008.01936.x","article-title":"Alterations of hepatic ATP homeostasis and respiratory chain during development of NASH in a rodent model","volume":"38","author":"Serviddio","year":"2008","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.jceh.2024.101368_bib23","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1001\/jama.282.17.1659","article-title":"Alterations in liver ATP homeostasis in human NASH: a pilot study","volume":"282","author":"Cortez-Pinto","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.jceh.2024.101368_bib24","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1136\/gut.2007.147496","article-title":"Uncoupling protein-2 (UCP2) induces mitochondrial proton leak and increases susceptibility of NASH liver to ischaemia-reperfusion injury","volume":"57","author":"Serviddio","year":"2008","journal-title":"Gut"},{"key":"10.1016\/j.jceh.2024.101368_bib25","first-page":"12","article-title":"Programmed cell death and its role in inflammation","volume":"2","author":"Yang","year":"2015","journal-title":"Mil Med Res"},{"key":"10.1016\/j.jceh.2024.101368_bib26","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.cmet.2015.04.004","article-title":"Adaptation of hepatic mitochondrial function in humans with NAFL is lost in steatohepatitis","volume":"21","author":"Koliaki","year":"2015","journal-title":"Cell Metabol"},{"key":"10.1016\/j.jceh.2024.101368_bib27","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.3109\/10715762.2015.1078461","article-title":"Endoplasmic reticulum stress and oxidative stress in the pathogenesis of NAFLD","volume":"49","author":"Ashraf","year":"2015","journal-title":"Free Radic Res"},{"key":"10.1016\/j.jceh.2024.101368_bib28","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1586\/egh.11.4","article-title":"Autophagy in NASH","volume":"5","author":"Amir","year":"2011","journal-title":"Expet Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2024.101368_bib29","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1158\/1055-9965.EPI-08-0725","article-title":"Iron overload is associated with hepatic oxidative damage to DNA in NASH","volume":"18","author":"Fujita","year":"2009","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.jceh.2024.101368_bib30","first-page":"5","article-title":"Normal iron metabolism and the pathophysiology of iron overload disorders","volume":"27","author":"Siah","year":"2006","journal-title":"Clin Biochem Rev"},{"key":"10.1016\/j.jceh.2024.101368_bib31","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1053\/j.gastro.2016.02.066","article-title":"Pathogenesis of nonalcoholic steatohepatitis","volume":"150","author":"Machado","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jceh.2024.101368_bib32","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.jhep.2004.01.028","article-title":"Polymorphisms of microsomal triglyceride transfer protein gene and manganese superoxide dismutase gene in NASH","volume":"40","author":"Namikawa","year":"2004","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2024.101368_bib33","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1055\/s-0035-1550065","article-title":"Fibrosis in NAFLD: mechanisms and clinical implications","volume":"35","author":"Angulo","year":"2015","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.jceh.2024.101368_bib34","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1515\/CCLM.2011.001","article-title":"Non-invasive assessment of liver fibrosis: it is time for laboratory medicine","volume":"49","author":"Sebastiani","year":"2011","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.jceh.2024.101368_bib35","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/lt.23566","article-title":"Long-term management of the successful adult liver transplant: 2012 practice guideline by the American Association for the study of liver diseases and the American Society of Transplantation","volume":"19","author":"Lucey","year":"2013","journal-title":"Liver Transplant"},{"key":"10.1016\/j.jceh.2024.101368_bib36","doi-asserted-by":"crossref","first-page":"224","DOI":"10.3109\/00365521.2014.983156","article-title":"Noninvasive characterization of graft steatosis after liver transplantation","volume":"50","author":"Karlas","year":"2015","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.jceh.2024.101368_bib37","article-title":"Assessment of steatosis and fibrosis in liver transplant recipients using controlled attenuation parameter and liver stiffness measurements","volume":"2021","author":"Mikolasevic","year":"2021","journal-title":"Chin J Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2024.101368_bib38","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.transproceed.2020.02.160","article-title":"The utility of assessing liver allograft fibrosis and steatosis post-liver transplantation using transient elastography with controlled attenuation parameter","volume":"53","author":"Chayanupatkul","year":"2021","journal-title":"Transplant Proc"},{"key":"10.1016\/j.jceh.2024.101368_bib39","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-69571-1","article-title":"Hepatic steatosis and liver fat contents in liver transplant recipients are associated with serum adipokines and insulin resistance","volume":"10","author":"Eshraghian","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.jceh.2024.101368_bib40","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1002\/hep.23050","article-title":"(\u201cThe Role of Elastography in Non-Alcoholic Fatty Liver Disease\u201d) Cytokeratin-18 fragment levels as noninvasive biomarkers for nonalcoholic steatohepatitis: a multicenter validation study","volume":"50","author":"Feldstein","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2024.101368_bib41","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/j.cgh.2008.07.016","article-title":"Cytokeratin 18 fragment levels as a noninvasive biomarker for nonalcoholic steatohepatitis in bariatric surgery patients","volume":"6","author":"Diab","year":"2008","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2024.101368_bib42","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1038\/ajg.2013.168","article-title":"Serum cytokeratin-18 fragment levels are useful biomarkers for nonalcoholic steatohepatitis in children","volume":"108","author":"Feldstein","year":"2013","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jceh.2024.101368_bib43","doi-asserted-by":"crossref","first-page":"617","DOI":"10.3109\/07853890.2010.518623","article-title":"Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity","volume":"43","author":"Musso","year":"2011","journal-title":"Ann Med"},{"key":"10.1016\/j.jceh.2024.101368_bib44","article-title":"Prognostic value of serum caspase-cleaved cytokeratin-18 levels before liver transplantation for one-year survival of patients with hepatocellular carcinoma","volume":"17","author":"Lorente","year":"2016","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jceh.2024.101368_bib45","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/891516","article-title":"Posttransplant metabolic syndrome","volume":"2012","author":"Siddiqui","year":"2012","journal-title":"Int. J Hepatol"},{"key":"10.1016\/j.jceh.2024.101368_bib46","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1002\/lt.23936","article-title":"Recurrent or de novo nonalcoholic fatty liver disease after liver transplantation: natural history based on liver biopsy analysis","volume":"20","author":"Vallin","year":"2014","journal-title":"Liver Transplant"},{"key":"10.1016\/j.jceh.2024.101368_bib47","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/lt.22004","article-title":"Nonalcoholic fatty liver disease after liver transplantation for cryptogenic cirrhosis or nonalcoholic fatty liver disease","volume":"16","author":"Yalamanchili","year":"2010","journal-title":"Liver Transplant"},{"key":"10.1016\/j.jceh.2024.101368_bib48","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1053\/jlts.2001.23011","article-title":"Development of nonalcoholic fatty liver disease after orthotopic liver transplantation for cryptogenic cirrhosis","volume":"7","author":"Contos","year":"2001","journal-title":"Liver Transplant"},{"key":"10.1016\/j.jceh.2024.101368_bib49","doi-asserted-by":"crossref","first-page":"e14","DOI":"10.1097\/TP.0000000000002317","article-title":"Recurrent or de novo allograft steatosis and long-term outcomes after liver transplantation","volume":"103","author":"Narayanan","year":"2019","journal-title":"Transplantation"},{"key":"10.1016\/j.jceh.2024.101368_bib50","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1111\/tri.12694","article-title":"Liver transplantation for nonalcoholic steatohepatitis in young patients","volume":"29","author":"Alkhouri","year":"2016","journal-title":"Transpl Int"},{"key":"10.1016\/j.jceh.2024.101368_bib51","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1097\/00007890-200007270-00009","article-title":"Comparative allograft histology after liver transplantation for cryptogenic cirrhosis, alcohol, hepatitis C, and cholestatic liver diseases","volume":"70","author":"Maor-Kendler","year":"2000","journal-title":"Transplantation"},{"key":"10.1016\/j.jceh.2024.101368_bib52","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1002\/lt.25338","article-title":"Predictors of de novo nonalcoholic fatty liver disease after liver transplantation and associated fibrosis","volume":"25","author":"Galvin","year":"2019","journal-title":"Liver Transplant"},{"key":"10.1016\/j.jceh.2024.101368_bib53","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/lt.22198","article-title":"Metabolic syndrome in liver transplant recipients: prevalence, risk factors, and association with cardiovascular events","volume":"17","author":"Laish","year":"2011","journal-title":"Liver Transplant"},{"key":"10.1016\/j.jceh.2024.101368_bib54","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/j.lts.2003.09.018","article-title":"Evolution of liver transplantation in Europe: report of the European liver transplant registry","volume":"9","author":"Adam","year":"2003","journal-title":"Liver Transplant"},{"key":"10.1016\/j.jceh.2024.101368_bib55","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/TP.0000000000002113","article-title":"Gender, race and disease etiology predict de novo malignancy risk after liver transplantation: insights for future individualized cancer screening guidance","volume":"103","author":"Bhat","year":"2019","journal-title":"Transplantation"},{"key":"10.1016\/j.jceh.2024.101368_bib56","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/j.1432-2277.2004.00067.x","article-title":"Weight gain and obesity after liver transplantation","volume":"18","author":"Richards","year":"2005","journal-title":"Transpl Int"},{"key":"10.1016\/j.jceh.2024.101368_bib57","first-page":"3","article-title":"Prevalence and risk factors of overweight and obesity after liver transplantation: retrospective study at three years after transplantation","volume":"71","author":"Di Cosmo","year":"2018","journal-title":"Prof Inferm"},{"key":"10.1016\/j.jceh.2024.101368_bib58","doi-asserted-by":"crossref","first-page":"317","DOI":"10.21037\/hbsn.2017.01.12","article-title":"Changes in dietary patterns and body composition within 12 months of liver transplantation","volume":"6","author":"McCoy","year":"2017","journal-title":"Hepatobiliary Surg Nutr"},{"key":"10.1016\/j.jceh.2024.101368_bib59","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1111\/j.1600-6143.2006.01391.x","article-title":"A\u00a0randomized trial of exercise and dietary counselling after liver transplantation","volume":"6","author":"Krasnoff","year":"2006","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jceh.2024.101368_bib60","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1111\/j.1432-2277.2006.00379.x","article-title":"Orlistat treatment is safe in overweight and obese liver transplant recipients: a prospective, open label trial","volume":"19","author":"Cassiman","year":"2006","journal-title":"Transpl Int"},{"key":"10.1016\/j.jceh.2024.101368_bib61","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1097\/TP.0000000000001913","article-title":"Everolimus is associated with less weight gain than tacrolimus 2 years after liver transplantation: results of a randomized multicentre study","volume":"101","author":"Charlton","year":"2017","journal-title":"Transplantation"},{"key":"10.1016\/j.jceh.2024.101368_bib62","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.soard.2013.02.013","article-title":"Laparoscopic sleeve gastrectomy is safe and efficacious for pretransplant candidates","volume":"9","author":"Lin","year":"2013","journal-title":"Surg Obes Relat Dis"},{"key":"10.1016\/j.jceh.2024.101368_bib63","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1097\/00007890-200109270-00015","article-title":"Posttransplant diabetes mellitus in liver transplant recipients: risk factors, temporal relationship with hepatitis C virus allograft hepatitis, and impact on mortality","volume":"72","author":"Baid","year":"2001","journal-title":"Transplantation"},{"key":"10.1016\/j.jceh.2024.101368_bib64","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0163-7258(02)00297-8","article-title":"Mechanisms involved in the\u00a0side effects of glucocorticoids","volume":"96","author":"Sch\u00e4cke","year":"2002","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.jceh.2024.101368_bib65","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1002\/hep4.1876","article-title":"Personalizing diabetes management in liver transplant recipients: the new era for optimizing risk management","volume":"6","author":"Richardson","year":"2022","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.jceh.2024.101368_bib66","doi-asserted-by":"crossref","first-page":"100","DOI":"10.12659\/AOT.882641","article-title":"Hypertension in solid organ transplant recipients","volume":"17","author":"Zbroch","year":"2012","journal-title":"Ann Transplant"},{"key":"10.1016\/j.jceh.2024.101368_bib67","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.3748\/wjg.v26.i18.2138","article-title":"Medical management of metabolic and cardiovascular complications after liver transplantation","volume":"26","author":"Becchetti","year":"2020","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jceh.2024.101368_bib68","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1111\/j.1440-1746.2008.05461.x","article-title":"Liver disease and the renin-angiotensin system: recent discoveries and clinical implications","volume":"23","author":"Lubel","year":"2008","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2024.101368_bib69","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1002\/lt.20932","article-title":"De novo nonalcoholic fatty liver disease after liver transplantation","volume":"13","author":"Seo","year":"2007","journal-title":"Liver Transplant"},{"key":"10.1016\/j.jceh.2024.101368_bib70","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1002\/lt.500030409","article-title":"Hyperlipidemia in liver transplant recipients: prevalence and risk factors","volume":"3","author":"Gisbert","year":"1997","journal-title":"Liver Transplant Surg"},{"key":"10.1016\/j.jceh.2024.101368_bib71","doi-asserted-by":"crossref","first-page":"125","DOI":"10.5500\/wjt.v6.i1.125","article-title":"Post-transplant dyslipidemia: mechanisms, diagnosis and management","volume":"6","author":"Agarwal","year":"2016","journal-title":"World J Transplant"},{"key":"10.1016\/j.jceh.2024.101368_bib72","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1111\/j.1365-2036.2004.01923.x","article-title":"Sirolimus-induced hyperlipidaemia in liver transplant recipients is not dose-dependent","volume":"19","author":"Firpi","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jceh.2024.101368_bib73","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1194\/jlr.M100392-JLR200","article-title":"Effects of sirolimus on plasma lipids, lipoprotein levels, and fatty acid metabolism in renal transplant patients","volume":"43","author":"Morrisett","year":"2002","journal-title":"J\u00a0Lipid Res"},{"key":"10.1016\/j.jceh.2024.101368_bib74","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ejim.2015.12.022","article-title":"Changes in lipid and carbohydrate metabolism under mTOR- and calcineurin-based immunosuppressive regimen in adult patients after liver transplantation","volume":"29","author":"Zimmermann","year":"2016","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.jceh.2024.101368_bib75","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/j.1399-0012.2007.00780.x","article-title":"Incidence of adverse events with HMGCoA reductase inhibitors in liver transplant patients","volume":"22","author":"Martin","year":"2008","journal-title":"Clin Transplant"},{"key":"10.1016\/j.jceh.2024.101368_bib76","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1592\/phco.27.5.715","article-title":"Role of prescription omega-3 fatty acids in the treatment of hypertriglyceridemia","volume":"27","author":"McKenney","year":"2007","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.jceh.2024.101368_bib77","doi-asserted-by":"crossref","first-page":"367","DOI":"10.2165\/00003495-200363040-00003","article-title":"Interactions between cyclosporin and lipid-lowering drugs: implications for organ transplant recipients","volume":"63","author":"Asberg","year":"2003","journal-title":"Drugs"},{"key":"10.1016\/j.jceh.2024.101368_bib78","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1002\/lt.21710","article-title":"Safety and effectiveness of ezetimibe in liver transplant recipients with hypercholesterolemia","volume":"15","author":"Almutairi","year":"2009","journal-title":"Liver Transplant"},{"key":"10.1016\/j.jceh.2024.101368_bib79","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.amjcard.2006.01.089","article-title":"Cardiac hemodynamic and coronary angiographic characteristics of patients being\u00a0evaluated for liver transplantation","volume":"98","author":"Tiukinhoy-Laing","year":"2006","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jceh.2024.101368_bib80","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1002\/lt.22468","article-title":"Cumulative risk of cardiovascular events after orthotopic liver transplantation","volume":"18","author":"Albeldawi","year":"2012","journal-title":"Liver Transplant"},{"key":"10.1016\/j.jceh.2024.101368_bib81","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1097\/00007890-200203270-00012","article-title":"Cardiovascular morbidity and mortality after orthotopic liver transplantation","volume":"73","author":"Johnston","year":"2002","journal-title":"Transplantation"},{"key":"10.1016\/j.jceh.2024.101368_bib82","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1111\/j.1399-0012.1995.tb00368.x","article-title":"Cardiovascular complications following liver transplantation","volume":"9","author":"Dec","year":"1995","journal-title":"Clin Transplant"},{"key":"10.1016\/j.jceh.2024.101368_bib83","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1002\/hep.25855","article-title":"Patients transplanted for nonalcoholic steatohepatitis are at increased risk for postoperative cardiovascular events","volume":"56","author":"Vanwagner","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2024.101368_bib84","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1002\/lt.21524","article-title":"The significance of metabolic syndrome in the setting of recurrent hepatitis C after liver transplantation","volume":"14","author":"Hanouneh","year":"2008","journal-title":"Liver Transplant"},{"key":"10.1016\/j.jceh.2024.101368_bib85","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1002\/lt.22417","article-title":"A\u00a0randomized, multicenter study comparing steroid-free immunosuppression and standard immunosuppression for liver transplant recipients with chronic hepatitis C","volume":"17","author":"Klintmalm","year":"2011","journal-title":"Liver Transplant"},{"key":"10.1016\/j.jceh.2024.101368_bib86","doi-asserted-by":"crossref","first-page":"3627","DOI":"10.3748\/wjg.v18.i28.3627","article-title":"Metabolic syndrome after liver transplantation: preventable illness or common consequence?","volume":"18","author":"Kallwitz","year":"2012","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jceh.2024.101368_bib87","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1097\/TP.0000000000001709","article-title":"Long-term outcomes in patients undergoing liver trans- plantation for nonalcoholic steatohepatitis-related cirrhosis","volume":"101","author":"Bhati","year":"2017","journal-title":"Transplantation"}],"container-title":["Journal of Clinical and Experimental Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0973688324000252?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0973688324000252?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,13]],"date-time":"2024-11-13T14:49:55Z","timestamp":1731509395000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0973688324000252"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":87,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["S0973688324000252"],"URL":"https:\/\/doi.org\/10.1016\/j.jceh.2024.101368","relation":{},"ISSN":["0973-6883"],"issn-type":[{"value":"0973-6883","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Post-Liver Transplant Metabolic Syndrome","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical and Experimental Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jceh.2024.101368","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Indian National Association for Study of the Liver. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"101368"}}